1Hardiman P,Pillay OS,Atioma W.Polycystic ovary syndrome and endometrial carcinoma[J].Lancet,2003,361 (9371):1801-1812.
2Daunaif A,Segal KR,Futterweit W,et al.Profound peripheral insulin resistance,independent of obesity in polycystic ovary syndrome[J].Diabetes,1989,38 (9):1165-1174.
3Mukders AG,Eijkeraane MJ,Imani B,et al.Prediction of chances for success and complications in gonadotrophin ovulation induction in normogonadotropic anovulatory infertility[J].RBM Online,2003,7(1):48-56.
4The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J].Fertil Steril,2004,81(1):19-25.
5Legro RS.Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome[J].J Pediatr Endocrinol Metab,2002,15 (Suppl 5):1367-1378.
6Strowitzki T,Halser B,Demant T.Body fat distribution,insulin sensitivity,ovarian dysfunction and serum lipoproteins in patients with polycystic ovary syndrome[J].Gynecol Endocrinol,2002,16(1):45-51.
7Koivunen R,Laatikainen T,Tomas C,et al.The prevalence of polycystic ovaries in healthy Scand women[J].Acta Obstet Gynecol,1999,78(2):137-141.
8Beloei C,Giuliani M,Suriano R,et al.Diagnosis of polycystic ovary syndrome[J].Minerva Gynecol,2004,56(1):7-13.
9Saleh AM,Khalil HS.Review of nonsurgical and surgical treatment and the role of insulin sensitizing agents in the management of infertile women with polycystic ovary syndrome[J].Acta Obstet Gynecol Scand,2004,83 (7):614 -621.
10Eid GM,Cottam DR,Velcu LM,et al.Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass[J].Surg Obesity Related Dis,2005,1 (2):77-80.
二级参考文献33
1Kaaijk EM,Sasano H,Suzuki T,et al. Distribution of steroidogenic enzymes involved in androgen synthesis in polycystic ovaries: an immunohistochemical study.Mol Hum Reprod, 2000,6:443-447.
2Pirwany IR, Yates RW, Cameron IT, et al. Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhoea.Hum Reprod, 1999,14:2963-2968.
4Greenblatt E, Casper RF. Endocrine changes after laparoscopic ovarian cautery in polycystic ovarian syndrome. Am J Obstet Gynecol,1987,42:517-518.
5Rossmanith WG, Keckstein J, Spatzier K, et al. The impact of ovarian laser surgery on the gonadotrophin secretion in women with polycystic ovarian disease.Clin Endocrinol,1991,34:223-230.
6Sumioki H, Utsunomiya T. Ovarian drilling. In: Kempers R, Cohen J, Haney AF, et al, eds. Fertility and reproduction medicine. New York: Elsevier Science,1998.537-539.
7Tropeano G, Liberale I, Vuolo IP, et al. Effects of ovary suppression by a long-acting GnRH-agonist on circulating GH, insulin-like growth factor I and insulin levels in women with polycystic ovary syndrome. J Endocrinol Invest, 1997,20:220-224.
8Young RH. Dusting off old books: comments on classic gynecologic pathology books of yesteryear.Int J Gynecol Pathol, 2000,19:67-84.
9Ferraretti AP, Gianaroli L, Magli MC, et al. Transvaginal ovarian drilling: a new surgical treatment for improving the clinical outcome of assisted reproductive technologies in patients with polycystic ovary syndrome.Fertil Steril, 2001,76:812-816.
10Russell JB, Knezevich KM, Fabian KF,et al. Unstimulated immature oocyte retrieval: early versus midfollicular endometrial priming.Fertil Steril, 1997,67:616-620.
